Supernus Pharmaceuticals
SUPN
#4017
Rank
โ‚ฌ2.47 B
Marketcap
42,93ย โ‚ฌ
Share price
-2.51%
Change (1 day)
43.91%
Change (1 year)

Market capitalization of Supernus Pharmaceuticals (SUPN)

Market cap: โ‚ฌ2.47 Billion

As of March 2026 Supernus Pharmaceuticals has a market cap of โ‚ฌ2.47 Billion. This makes Supernus Pharmaceuticals the world's 4017th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Supernus Pharmaceuticals from 2012 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ2.47 B-1.8%
2025โ‚ฌ2.51 B27.59%
2024โ‚ฌ1.97 B37.94%
2023โ‚ฌ1.43 B-20.44%
2022โ‚ฌ1.79 B31.28%
2021โ‚ฌ1.36 B26.62%
2020โ‚ฌ1.08 B-2.78%
2019โ‚ฌ1.11 B-26.78%
2018โ‚ฌ1.51 B-10.77%
2017โ‚ฌ1.70 B43.17%
2016โ‚ฌ1.18 B97.42%
2015โ‚ฌ0.60 B105.39%
2014โ‚ฌ0.29 B34.35%
2013โ‚ฌ0.21 B31.52%
2012โ‚ฌ0.16 B

End of Day market cap according to different sources

On Mar 28th, 2026 the market cap of Supernus Pharmaceuticals was reported to be:

โ‚ฌ2.46 Billion
by Nasdaq info icon info icon
โ‚ฌ2.47 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ502.34 B 20,221.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚ฌ156.65 B 6,237.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ681.43 B 27,466.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ103.61 B 4,091.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Zogenix
ZGNX
โ‚ฌ1.30 B-47.39%๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
โ‚ฌ19.86 B 703.61%๐Ÿ‡บ๐Ÿ‡ธ USA